313 related articles for article (PubMed ID: 32268494)
1. Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target.
Battista T; Fiorillo A; Chiarini V; Genovese I; Ilari A; Colotti G
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32268494
[TBL] [Abstract][Full Text] [Related]
2. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
3. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
4. Sorcin, a calcium binding protein involved in the multidrug resistance mechanisms in cancer cells.
Colotti G; Poser E; Fiorillo A; Genovese I; Chiarini V; Ilari A
Molecules; 2014 Sep; 19(9):13976-89. PubMed ID: 25197934
[TBL] [Abstract][Full Text] [Related]
5. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
6. The potential mechanism of action of Sorcin and its interacting proteins.
Mao J; Ling F; Gislaine Pires Sanches J; Yu X; Wei Y; Zhang J
Clin Chim Acta; 2020 Nov; 510():741-745. PubMed ID: 32946798
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
Yamagishi N; Nakao R; Kondo R; Nishitsuji M; Saito Y; Kuga T; Hatayama T; Nakayama Y
Biochem Biophys Res Commun; 2014 Jun; 448(4):430-6. PubMed ID: 24796664
[TBL] [Abstract][Full Text] [Related]
8. Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an
Ji N; Yang Y; Cai CY; Wang JQ; Lei ZN; Wu ZX; Cui Q; Yang DH; Chen ZS; Kong D
Front Oncol; 2019; 9():514. PubMed ID: 31275850
[TBL] [Abstract][Full Text] [Related]
9. Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells.
Genovese I; Fiorillo A; Ilari A; Masciarelli S; Fazi F; Colotti G
Cell Death Dis; 2017 Jul; 8(7):e2950. PubMed ID: 28726784
[TBL] [Abstract][Full Text] [Related]
10. Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma.
Liu X; Chen L; Feng B; Liu G
Anat Rec (Hoboken); 2014 Feb; 297(2):215-21. PubMed ID: 24376145
[TBL] [Abstract][Full Text] [Related]
11. Sorcin a Potential Molecular Target for Cancer Therapy.
Shabnam B; Padmavathi G; Banik K; Girisa S; Monisha J; Sethi G; Fan L; Wang L; Mao X; Kunnumakkara AB
Transl Oncol; 2018 Dec; 11(6):1379-1389. PubMed ID: 30216763
[TBL] [Abstract][Full Text] [Related]
12. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
13. Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.
Liao D; Zhang W; Gupta P; Lei ZN; Wang JQ; Cai CY; Vera AA; Zhang L; Chen ZS; Yang DH
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801248
[TBL] [Abstract][Full Text] [Related]
14. Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.
Wu CP; Hung TH; Hsiao SH; Huang YH; Hung LC; Yu YJ; Chang YT; Wang SP; Wu YS
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32466597
[TBL] [Abstract][Full Text] [Related]
15. Combination of dihydromyricetin and ondansetron strengthens antiproliferative efficiency of adriamycin in K562/ADR through downregulation of SORCIN: A new strategy of inhibiting P-glycoprotein.
Sun Y; Liu W; Wang C; Meng Q; Liu Z; Huo X; Yang X; Sun P; Sun H; Ma X; Peng J; Liu K
J Cell Physiol; 2019 Apr; 234(4):3685-3696. PubMed ID: 30171603
[TBL] [Abstract][Full Text] [Related]
16. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
17. VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.
Ji N; Yang Y; Cai CY; Lei ZN; Wang JQ; Gupta P; Teng QX; Chen ZS; Kong D; Yang DH
Front Pharmacol; 2018; 9():1236. PubMed ID: 30425643
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of sorcin overexpression to multidrug resistance of human gastric cancer cell line SGC7901].
He QC; Zhang GY; Cao WJ
Ai Zheng; 2008 Apr; 27(4):337-42. PubMed ID: 18423116
[TBL] [Abstract][Full Text] [Related]
19. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
20. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.
Chen Z; Shi T; Zhang L; Zhu P; Deng M; Huang C; Hu T; Jiang L; Li J
Cancer Lett; 2016 Jan; 370(1):153-64. PubMed ID: 26499806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
